Hansen Pernille B L
Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, Denmark
Am J Physiol Regul Integr Comp Physiol. 2015 Feb 15;308(4):R227-37. doi: 10.1152/ajpregu.00276.2014. Epub 2014 Dec 17.
Over the years, it has been discussed whether T-type calcium channels Cav3 play a role in the cardiovascular and renal system. T-type channels have been reported to play an important role in renal hemodynamics, contractility of resistance vessels, and pacemaker activity in the heart. However, the lack of highly specific blockers cast doubt on the conclusions. As new T-type channel antagonists are being designed, the roles of T-type channels in cardiovascular and renal pathology need to be elucidated before T-type blockers can be clinically useful. Two types of T-type channels, Cav3.1 and Cav3.2, are expressed in blood vessels, the kidney, and the heart. Studies with gene-deficient mice have provided a way to investigate the Cav3.1 and Cav3.2 channels and their role in the cardiovascular system. This review discusses the results from these knockout mice. Evaluation of the literature leads to the conclusion that Cav3.1 and Cav3.2 channels have important, but different, functions in mice. T-type Cav3.1 channels affect heart rate, whereas Cav3.2 channels are involved in cardiac hypertrophy. In the vascular system, Cav3.2 activation leads to dilation of blood vessels, whereas Cav3.1 channels are mainly suggested to affect constriction. The Cav3.1 channel is also involved in neointima formation following vascular damage. In the kidney, Cav3.1 regulates plasma flow and Cav3.2 plays a role setting glomerular filtration rate. In conclusion, Cav3.1 and Cav3.2 are new therapeutic targets in several cardiovascular pathologies, but the use of T-type blockers should be specifically directed to the disease and to the channel subtype.
多年来,一直有人讨论T型钙通道Cav3是否在心血管系统和肾脏系统中发挥作用。据报道,T型通道在肾脏血流动力学、阻力血管收缩性及心脏起搏活动中发挥重要作用。然而,缺乏高度特异性的阻滞剂使得这些结论受到质疑。随着新型T型通道拮抗剂的设计研发,在T型阻滞剂具有临床实用性之前,需要阐明T型通道在心血管和肾脏病理中的作用。两种类型的T型通道,即Cav3.1和Cav3.2,在血管、肾脏和心脏中均有表达。对基因缺陷小鼠的研究为探究Cav3.1和Cav3.2通道及其在心血管系统中的作用提供了一种方法。本综述讨论了这些基因敲除小鼠的研究结果。对文献的评估得出结论,Cav3.1和Cav3.2通道在小鼠中具有重要但不同的功能。T型Cav3.1通道影响心率,而Cav3.2通道与心肌肥厚有关。在血管系统中,Cav3.2激活导致血管扩张,而Cav3.1通道主要被认为影响血管收缩。Cav3.1通道还参与血管损伤后的内膜增生。在肾脏中,Cav3.1调节血浆流量,Cav3.2在设定肾小球滤过率中发挥作用。总之,Cav3.1和Cav3.2是几种心血管疾病新的治疗靶点,但T型阻滞剂的使用应针对具体疾病和通道亚型。